Literature DB >> 15358395

Time-dependent bias was common in survival analyses published in leading clinical journals.

Carl van Walraven1, Darryl Davis, Alan J Forster, George A Wells.   

Abstract

OBJECTIVE: In survival analysis, "baseline immeasurable" time-dependent factors cannot be recorded at baseline, and change value after patient observation starts. Time-dependent bias can occur if such variables are not analyzed appropriately. This study sought to determine the prevalence of such time-dependent bias in highly-cited medical journals. STUDY DESIGN AND
SETTING: We searched Medline databases to identify all observational studies that used a survival analysis in American Journal of Medicine, Annals of Internal Medicine, Archives of Internal Medicine, British Medical Journal, Chest, Circulation, Journal of the American Medical Association, Lancet, and New England Journal of Medicine between 1998 and 2002. Studies with "baseline immeasurable" time-dependent factors were susceptible to time-dependent bias if a time-dependent covariate analysis was not used.
RESULTS: Of 682 eligible studies, 127 (18.6%, 95% CI 15.8-21.8%) contained a "baseline immeasurable" time-dependent factor and 52 (7.6% [5.8-9.9%] of all survival analyses/40.9% [32.3-50.0%] of studies with a time-dependent factor) were susceptible to time-dependent bias. In 35 studies (5.1% [3.7-7.1%]/27.6% [20.5-35.9%]), the bias affected a variable highlighted in the study abstract and correction of the bias could have qualitatively changed the study's conclusion in over half of studies.
CONCLUSION: In medical journals, time-dependent bias is concerningly common and frequently affects key factors and the study's conclusion.

Entities:  

Mesh:

Year:  2004        PMID: 15358395     DOI: 10.1016/j.jclinepi.2003.12.008

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  82 in total

1.  A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae.

Authors:  Giannoula S Tansarli; Nikolaos Andreatos; Elina E Pliakos; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital.

Authors:  Alan J Forster; Monica Taljaard; Natalie Oake; Kumanan Wilson; Virginia Roth; Carl van Walraven
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

3.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

4.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

Review 5.  Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.

Authors:  Jordana K Schmier; Michael T Halpern; Mechelle L Jones
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Mandatory ECG screening of athletes: is this question now resolved?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

Review 7.  Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.

Authors:  Judith M Graber; Shou-En Lu; Yong Lin; Grace Lu-Yao; Xiang-Lin Tan
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 8.  Does Higher Spending Improve Survival Outcomes for Myocardial Infarction? Examining the Cost-Outcomes Relationship Using Time-Varying Covariates.

Authors:  Deborah Cohen; Douglas G Manuel; Peter Tugwell; Claudia Sanmartin; Tim Ramsay
Journal:  Health Serv Res       Date:  2015-02-09       Impact factor: 3.402

9.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

10.  Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies.

Authors:  Ayumi K Shintani; Timothy D Girard; Svetlana K Eden; Patrick G Arbogast; Karel G M Moons; E Wesley Ely
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.